A comparison of 'Integrin' and 'Tacitin' in the treatment of anxiety neurosis in general practice.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001290:Attitude; D001519:Behavior / Q000187:drug effects; D003863:Depression / Q000188:drug therapy; D005194:Family Practice; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D013997:Time Factors; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D000873:Anthracenes; D007211:Indoles; D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents